Risk of second primary cancer and death in patients with idiopathic inflammatory myopathies.
To assess the risk of second primary cancer and death in patients who has a cancer diagnosis following idiopathic inflammatory myopathies (IIM). Using nationwide Swedish healthcare and population registers, we identified 2346 patients diagnosed with IIM ≥18 years of age b…